RFID Tags Cost Prohibitive For OTCs; Pilot Studies Underway For Rx Drugs
This article was originally published in The Tan Sheet
Executive Summary
The up-front expense of using radiofrequency identification (RFID) technology could preclude OTC drug manufacturers from placing the tags on their drugs for the foreseeable future
You may also be interested in...
Prilosec OTC Demand Taxing P&G Supply Chain Efficiency
Procter & Gamble is addressing shortfalls in its supply chain in order to meet higher than expected customer demand for Prilosec OTC
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands